Literature DB >> 17004273

Protein-free transfection of CHO host cells with an IgG-fusion protein: selection and characterization of stable high producers and comparison to conventionally transfected clones.

Christine Lattenmayer1, Martina Loeschel, Kornelia Schriebl, Willibald Steinfellner, Thomas Sterovsky, Evelyn Trummer, Karola Vorauer-Uhl, Dethardt Müller, Hermann Katinger, Renate Kunert.   

Abstract

In order to improve the current techniques of cell cultivation in the absence of serum, we have developed a protein-free transfection protocol for CHO cells, based on the Nucleofector technology. After starting with a heterogeneous pool of primary transfectants which express the fusion protein EpoFc, we isolated single clones and compared them with parallel clones generated by lipofection in serum-dependent cultivation. Our intensive characterization program was based on determination of specific productivity (q(p)) and analysis of genetic parameters. In two nucleofection experiments, transfection with 5 microg of DNA resulted in best productivities of the primary cell pools. After subcloning, the q(p) could be raised up to 27 pg x cells(-1) x day(-1). While the serum-dependent transfectants exhibited specific productivities up to 57 pg x cells(-1) x day(-1) in serum-dependent cultivation, a significant decrease that resulted in the range of q(p) of the protein-free transfectants was observed after switching to protein-free conditions. Investigation of genetic parameters revealed higher mRNA levels and gene copy numbers (GCN) for the protein-free adapted serum-dependent transfectants. Therefore, we assume that problems during protein-free adaptation (PFA) lead to a less efficient translation machinery after serum deprivation. We describe the generation of stable-producing recombinant CHO clones by protein-free transfection of a protein-free adapted host cell line, which reduces the risk of adverse clonal changes after PFA. The main advantage of this approach is the earlier predictability of clone behavior, which makes the generation of production clones by protein-free transfection, a viable and highly efficient strategy for recombinant cell line development. (c) 2006 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17004273     DOI: 10.1002/bit.21183

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  10 in total

1.  C-Terminally fused affinity Strep-tag II is removed by proteolysis from recombinant human erythropoietin expressed in transgenic tobacco plants.

Authors:  Farooqahmed S Kittur; Mallikarjun Lalgondar; Chiu-Yueh Hung; David C Sane; Jiahua Xie
Journal:  Plant Cell Rep       Date:  2014-12-14       Impact factor: 4.570

Review 2.  Screening Strategies for High-Yield Chinese Hamster Ovary Cell Clones.

Authors:  Wenwen Yang; Junhe Zhang; Yunxi Xiao; Wenqing Li; Tianyun Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-06-17

3.  Evaluating the bottlenecks of recombinant IgM production in mammalian cells.

Authors:  Veronika Chromikova; Alexander Mader; Willibald Steinfellner; Renate Kunert
Journal:  Cytotechnology       Date:  2014-03-11       Impact factor: 2.058

4.  Next-generation sequencing of the Chinese hamster ovary microRNA transcriptome: Identification, annotation and profiling of microRNAs as targets for cellular engineering.

Authors:  Matthias Hackl; Tobias Jakobi; Jochen Blom; Daniel Doppmeier; Karina Brinkrolf; Rafael Szczepanowski; Stephan H Bernhart; Christian Höner Zu Siederdissen; Juan A Hernandez Bort; Matthias Wieser; Renate Kunert; Simon Jeffs; Ivo L Hofacker; Alexander Goesmann; Alfred Pühler; Nicole Borth; Johannes Grillari
Journal:  J Biotechnol       Date:  2011-03-30       Impact factor: 3.307

5.  Multi-omic profiling -of EPO-producing Chinese hamster ovary cell panel reveals metabolic adaptation to heterologous protein production.

Authors:  Daniel Ley; Ali Kazemi Seresht; Mikael Engmark; Olivera Magdenoska; Kristian Fog Nielsen; Helene Faustrup Kildegaard; Mikael Rørdam Andersen
Journal:  Biotechnol Bioeng       Date:  2015-06-30       Impact factor: 4.530

6.  A Microfluidic Single-Cell Cloning (SCC) Device for the Generation of Monoclonal Cells.

Authors:  Chuan-Feng Yeh; Ching-Hui Lin; Hao-Chen Chang; Chia-Yu Tang; Pei-Tzu Lai; Chia-Hsien Hsu
Journal:  Cells       Date:  2020-06-18       Impact factor: 6.600

7.  A cross-species whole genome siRNA screen in suspension-cultured Chinese hamster ovary cells identifies novel engineering targets.

Authors:  Gerald Klanert; Daniel J Fernandez; Marcus Weinguny; Peter Eisenhut; Eugen Bühler; Michael Melcher; Steven A Titus; Andreas B Diendorfer; Elisabeth Gludovacz; Vaibhav Jadhav; Su Xiao; Beate Stern; Madhu Lal; Joseph Shiloach; Nicole Borth
Journal:  Sci Rep       Date:  2019-06-18       Impact factor: 4.996

8.  Advances in Mammalian cell line development technologies for recombinant protein production.

Authors:  Tingfeng Lai; Yuansheng Yang; Say Kong Ng
Journal:  Pharmaceuticals (Basel)       Date:  2013-04-26

9.  Endogenous microRNA clusters outperform chimeric sequence clusters in Chinese hamster ovary cells.

Authors:  Gerald Klanert; Vaibhav Jadhav; Konstantina Chanoumidou; Johannes Grillari; Nicole Borth; Matthias Hackl
Journal:  Biotechnol J       Date:  2014-02-12       Impact factor: 4.677

10.  Stable overexpression of miR-17 enhances recombinant protein production of CHO cells.

Authors:  Vaibhav Jadhav; Matthias Hackl; Gerald Klanert; Juan A Hernandez Bort; Renate Kunert; Johannes Grillari; Nicole Borth
Journal:  J Biotechnol       Date:  2014-02-08       Impact factor: 3.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.